212:
Although the G proteins have weak hydrolytic activity, in the presence of functional GEFs, the inactivated G proteins are constantly replaced with activated ones because the GEFs exchange GDP for GTP in these proteins. With no GAPs to curb the G protein's activity, this results in constitutively active G proteins, unregulated cell growth, and the cancerous state. In the case of the latter, a loss of the G protein's ability to respond to GAP, the G proteins have lost their ability to hydrolyze GTP. With a nonfunctional G protein enzyme, GAPs cannot activate the GTPase activity, and the G protein is constitutively on. This also results in unregulated cell growth and cancer. Examples of GAP malfunction are ubiquitous clinically. Some cases involve a decreased expression of the GAP gene. For example, some recently characterized cases of
116:
location of protein expression. RGS9-1, for example, is specifically expressed in the rod and cone photoreceptors in the eye retina, and is the only one to interact with G proteins involved in phototransduction in this area. A certain GAP and a certain G protein happen to be expressed in the same time and place, and that is how the cell ensures specificity. Meanwhile, scaffold proteins can also sequester the proper GAP to its G protein and enhance the proper binding interactions. These binding interactions may be specific for a particular GAP and G protein. Also, GAPs may have particular amino acid domains that recognize only a particular G protein. Binding to other G proteins may not have the same favorable interactions, and they therefore do not interact. GAPs can, therefore, regulate specific G proteins.
175:
Such inhibition of GAP may perhaps "prime" the signaling pathway for activation. This creates a window of activity for the G proteins once activated because the GAP is temporarily inhibited. When the potassium channel is activated, Ca2+ gets released and binds calmodulin. Together, they displace PIP3 from GAP by binding competitively to the same site, and by doing so, they reactivate GAP to turn G protein signaling off. This particular process demonstrates both inhibition and activation of GAP by its regulators. There is cross-talk between GAP and other components of the signaling pathway that regulate the activity of GAP.
229:
of the G protein itself is lost. GAP works to activate a nonfunctional hydrolytic enzyme. T24 bladder cancer cells, for example, were shown to have a missense mutation, G12V, resulting in constitutively active Ras protein. Despite the presence of the G protein regulator, regulation is lost due to a loss of function in the G protein itself. This loss of function also manifests itself in cancer. GAPs and their interaction with G proteins are, therefore, highly important clinically and are potential targets for cancer therapies.
171:
interacts with cGMP phosphodiesterase (cGMP PDE), a downstream component of phototransduction in the retina. Upon binding with cGMP PDE, RGS9-1 GAP activity is enhanced. In other words, a downstream target of photoreceptor-induced signaling binds and activates the inhibitor of signaling, GAP. This positive regulatory binding of downstream targets to GAP serves as a negative feedback loop that eventually turns off the signaling that was originally activated. GAPs are regulated by targets of the G protein that they regulate.
79:
179:
One GAP serves as a negative regulator of another GAP. The reasons for such cross-regulation across GAPs are yet unclear, but one possible hypothesis is that this cross-talk across GAPs attenuates the "off" signal of all the GAPs. Although the p120Ras GAP is active, therefore inhibiting that particular pathway, other cellular processes can still continue because it inhibits other GAPs. This may ensure that the whole system does not shut down from a single
91:, which changes the conformation of the GTP-bound G protein to orient the GTP for better nucleophilic attack by water. This makes the GTP a better substrate for the reaction. Similarly, GAPs seem to induce a GDP-like charge distribution in the bound GTP. Because the change in charge distribution makes the GTP substrate more like the products of the reaction, GDP and monophosphate, this, along with opening the molecule for nucleophilic attack, lowers the
233:
204:
103:
221:
71:(GTP). Binding of GTP inherently changes the activity of the G proteins and increases their activity, through the loss of inhibitory subunits. In this more active state, G proteins can bind other proteins and turn on downstream signalling targets. This whole process is regulated by GAPs, which can down regulate the activity of G proteins.
199:
of G proteins, for example, has been associated with many cancers because Ras is a common downstream target of many growth factors like FGF, or fibroblast growth factor. Under normal conditions, this signaling ultimately induces regulated cell growth and proliferation. However, in the cancer state,
228:
Other cancers show a loss of sensitivity of the G protein to the GAPs. These G proteins acquire missense mutations that disrupt the inherent GTPase activity of the proteins. The mutant G proteins are still bound by GAPs, but enhancing GTPase activity by the GAPs is meaningless when GTPase activity
178:
There have been some findings suggesting the possibility of crosstalk between GAPs. A recent study showed that the p120Ras GAP could bind the DLC1 Rho GAP at its catalytic domain. The binding of the Ras GAP to the Rho GAP inhibits the activity of the Rho GAP, thereby activating the Rho G protein.
174:
There are also examples of negative regulatory mechanisms, where downstream targets of G protein signaling inhibit the GAPs. In G protein-gated potassium channels, phosphatidylinositol 3, 4, 5-triphosphate (PIP3) is a downstream target of G protein signaling. PIP3 binds and inhibits the RGS4 GAP.
74:
G proteins can weakly hydrolyse GTP, breaking a phosphate bond to make GDP. In the GDP-bound state, the G proteins are subsequently inactivated and can no longer bind their targets. This hydrolysis reaction, however, occurs very slowly, meaning G proteins have a built-in timer for their activity.
50:, or RGS proteins, and these proteins are crucial in controlling the activity of G proteins. Regulation of G proteins is important because these proteins are involved in a variety of important cellular processes. The large G proteins, for example, are involved in transduction of signaling from the
216:
cells in patients show a decreased expression of Rap1GAP, and this expression is seemingly caused by a decreased expression of the GAP mRNA, shown by qRT-PCR experiments. In this case, there appears to be a loss of proper Rap1GAP gene expression. In another case, expression of the Ras GAP is lost
115:
In general, GAPs tend to be pretty specific for their target G proteins. The exact mechanism of target specificity is not fully known, but it is likely that this specificity comes from a variety of factors. At the most basic level, GAP-to-G protein specificity may come simply from the timing and
98:
of the reaction and allows GTP to be hydrolyzed more readily. GAPs, then, work to enhance the GTP hydrolysis reaction of the G proteins. By doing so, they accelerate the G protein's built-in timer, which inactivates the G proteins more quickly, and along with the inactivation of GEFs, this keeps
170:
While GAPs serve to regulate the G proteins, there is also some level of regulation of the GAPs themselves. Many GAPs have allosteric sites that serve as interfaces with downstream targets of the particular path that they regulate. For example, RGS9-1, the GAP in the photoreceptors from above,
211:
Often, this oncogenic behavior is due to a loss of function of GAPs associated with those G proteins or a loss of the G protein's ability to respond to its GAP. With the former, G proteins are unable to hydrolyze GTP quickly, resulting in sustained expression of the active form of G proteins.
541:
Raepple, D. et al. "Determination of Ras-GTP and Ras-GDP in
Patients with Acute Myelogenous Leukemia (AML), Myeloproliferative Syndrome (MPS), Juvenile Myelomonocytic Leukemia (JMML), Acute Lymphocytic Leukemia (ALL), and Malignant Lymphoma: Assessment of Mutational and Indirect Activation".
54:
for a variety of signaling processes like hormonal signaling, and small G proteins are involved in processes like cellular trafficking and cell cycling. GAP's role in this function is to turn the G protein's activity off. In this sense, GAPs function is opposite to that of
86:
It is thought that GAPs serve to make GTP on the G protein a better substrate for nucleophilic attack and lower the transition state energy for the hydrolysis reaction. For example, many GAPs of the small G proteins have a conserved finger-like domain, usually an
217:
in several cancers due to improper epigenetic silencing of the gene. These cells have CpG methylations near the gene that, in effect, silence gene transcription. Regulation of G proteins is lost because the regulator is absent, resulting in cancer.
75:
G proteins have a window of activity followed by slow hydrolysis, which turns them off. GAP accelerates this G protein timer by increasing the hydrolytic GTPase activity of the G proteins, hence the name GTPase-activating protein.
150:, which is found in the cytosol as well as the nucleus. Hydrolysis of GTP by Ran is thought to provide the energy needed to transport nuclear proteins into the cell. Ran is turned on and off by GEFs and GAPs, respectively.
236:
G proteins without hydrolytic activity cannot hydrolyze bound GTP. GAPs cannot activate a nonfunctional enzyme, and the G protein is constitutively active, resulting in unregulated cell division and the formation of
479:
Ishii, Masaru et al. "Phosphatidylinositol 3,4,5-triphosphate and Ca2+/Calmodulin
Competitively Bind to the Regulators of G-Protein-Signaling (RGS) Domain of RGS4 and Reciprocally Regulate Its Action".
224:
Without GAP, G proteins are constitutively on because of their slow hydrolytic activity and GEFs constantly replacing GDP with GTP. This results in unregulated cell division and the formation of tumors.
604:
528:
Jin, Hongchuan et al. "Epigenetic
Silencing of a Ca2+-Regulated Ras GTPase-Activating Protein RASAL Defines a New Mechanism of Ras Activation in Human Cancers".
663:
1020:
597:
555:
Premkumar Reddy, E. et al. "A Point
Mutation is Responsible for the Acquisition of Transforming Properties by the T24 Human Bladder Carcinoma Oncogene".
191:
The importance of GAPs comes from its regulation of the crucial G proteins. Many of these G proteins are involved in cell cycling, and as such are known
434:
Rosqvist R, Forsberg A, Rimpiläinen M, Bergman T, Wolf-Watz H (April 1990). "The cytotoxic protein YopE of
Yersinia obstructs the primary host defence".
361:
Kötting, C. et al. "Time-Resolved FTIR Studies
Provide Activation Free Energy, Activation Enthalpy and Activation Entropy for GTPase Reactions".
1041:
590:
493:
Yang, Xu-Yu et al. "p120Ras-GAP Binds the DLC1 Rho-GAP Tumor
Suppressor Protein and Inhibits Its RhoA GTPase and Growth Suppressing Activities".
859:
266:
56:
82:
G proteins have an inherent GTPase hydrolytic activity that is slow. However, in the presence of GAP, this hydrolytic activity is fast.
815:
698:
159:
47:
304:
Xu, Haiming et al. "Loss of the Rho GTPase
Activating Protein p190-B Enhances Hematopoietic Stem Cell Engraftment Potential".
348:
Scheffzek, K. et al. "The Ras-RasGAP Complex: Structural Basis for GTPase
Activation and Its Loss in Oncogenic Ras Mutants".
613:
67:
GAP are heavily linked to the G-protein linked receptor family. The activity of G proteins comes from their ability to bind
291:
Kimple, A.J. "Structural
Determinants of G-protein α Subunit Selectivity by Regulator of G-protein Signaling 2 (RGS2)".
317:
Krendel, M. "Nucleotide Exchange Factor GEF-H1 Mediates Cross-Talk between Microtubules and the Actin Cytoskeleton".
670:
51:
576:
213:
78:
106:
GAP works to open the G protein for nucleophilic attack by water and induce a GDP-like charge distribution.
68:
131:
that is a Rho GTPase-activating protein (GAP), which targets small GTPases such as RhoA, Rac1, and Rac2.
183:
signal. GAP activity is highly dynamic, interacting with many other components of signaling pathways.
572:
506:
Berg et al. "Signal-Transduction Pathways". Biochemistry. New York: W.H. Freeman and Company, 2007.
158:
Most GAPs that act on alpha subunits of heterotrimeric G proteins belong to a distinct family, the
39:
459:
394:
1046:
451:
416:
262:
256:
95:
832:
443:
406:
92:
799:
379:
Xie, Guo-xi et al. "How Regulators of G Protein Signaling Achieve Selective Regulation".
232:
203:
102:
196:
192:
88:
17:
894:
447:
220:
128:
46:
activity, with the result of terminating the signaling event. GAPs are also known as
1035:
848:
658:
395:"Eukaryotic translation initiation factor 5 functions as a GTPase-activating protein"
207:
Normally, G proteins are regulated by GAP, which results in controlled cell division.
147:
140:
99:
the G protein signal off. GAPs, then, are critical in the regulation of G proteins.
463:
582:
530:
Proceedings of the National Academy of Sciences of the United States of America
646:
641:
420:
411:
200:
such growth is no longer regulated and results in the formation of tumors.
455:
38:) are a family of regulatory proteins whose members can bind to activated
837:
636:
906:
515:
Nellore, Anoma et al. "Loss of Rap1GAP in Papillary Thyroid Cancer".
996:
971:
966:
653:
43:
961:
951:
946:
941:
931:
926:
916:
911:
827:
794:
789:
784:
779:
774:
769:
764:
759:
754:
749:
231:
219:
202:
143:
superfamily have conserved structures and use similar mechanisms,
101:
77:
991:
986:
883:
878:
873:
868:
744:
739:
734:
729:
724:
719:
714:
709:
704:
680:
675:
124:
586:
139:
The GAPs that act on small GTP-binding proteins of the
127:
is a GTPase-activating protein. Furthermore, YopE is a
475:
473:
59:(GEFs), which serve to enhance G protein signaling.
1013:
892:
857:
846:
814:
691:
629:
620:
287:
285:
375:
373:
371:
258:Biochemistry of signal transduction and regulation
517:Journal of Clinical Endocrinology and Metabolism
335:Berg et al. "Signal-Transduction Pathways".
598:
8:
1021:Guanosine nucleotide dissociation inhibitors
339:. New York: W.H. Freeman and Company, 2007.
331:
329:
327:
187:Disease associations and clinical relevance
854:
820:
626:
605:
591:
583:
575:at the U.S. National Library of Medicine
410:
393:Das S, Ghosh R, Maitra U (March 2001).
247:
146:An example of a GTPase is the monomer
7:
293:The Journal of Biological Chemistry
57:guanine nucleotide exchange factors
816:Guanine nucleotide exchange factor
448:10.1111/j.1365-2958.1990.tb00635.x
25:
699:Regulator of G protein signalling
1042:GTP-binding protein regulators
614:GTP-binding protein regulators
1:
381:Journal of Molecular Biology
261:. Wiley-VCH. pp. 235–.
32:GTPase-accelerating proteins
532:. 104 (2007): 12353-12358.
295:. 284 (2009): 19402-19411.
120:Examples and classification
1063:
671:Tuberous sclerosis protein
573:GTPase-Activating+Proteins
52:G protein-coupled receptor
28:GTPase-activating proteins
18:GTPase activating proteins
982:
823:
622:GTPase activating protein
308:. 114 (2009): 3557–3566.
111:Specificity to G proteins
577:Medical Subject Headings
519:. 94 (2009): 1026–1032.
214:papillary thyroid cancer
559:. 300 (1982): 149–152.
497:. 28 (2009): 1401–1409.
383:. 366 (2007): 349–365.
365:. 307 (2004): 227–232.
352:. 277 (1997): 333–338.
255:Gerhard Krauss (2008).
546:. 88 (2009): 319–324.
412:10.1074/jbc.M008863200
238:
225:
208:
107:
83:
69:guanosine triphosphate
484:. 385 (2005): 65–73.
321:. 4 (2002): 294–301.
235:
223:
206:
105:
81:
544:Annals of Hematology
482:Biochemistry Journal
42:and stimulate their
319:Nature Cell Biology
239:
226:
209:
108:
84:
1029:
1028:
1009:
1008:
1005:
1004:
810:
809:
268:978-3-527-31397-6
16:(Redirected from
1054:
897:
862:
855:
851:
833:Son of Sevenless
821:
627:
607:
600:
593:
584:
560:
553:
547:
539:
533:
526:
520:
513:
507:
504:
498:
491:
485:
477:
468:
467:
431:
425:
424:
414:
390:
384:
377:
366:
363:Chemical Physics
359:
353:
346:
340:
333:
322:
315:
309:
302:
296:
289:
280:
279:
277:
275:
252:
93:transition state
21:
1062:
1061:
1057:
1056:
1055:
1053:
1052:
1051:
1032:
1031:
1030:
1025:
1001:
978:
893:
888:
858:
847:
842:
806:
687:
616:
611:
569:
564:
563:
554:
550:
540:
536:
527:
523:
514:
510:
505:
501:
492:
488:
478:
471:
433:
432:
428:
392:
391:
387:
378:
369:
360:
356:
347:
343:
334:
325:
316:
312:
303:
299:
290:
283:
273:
271:
269:
254:
253:
249:
244:
197:Ras superfamily
193:proto-oncogenes
189:
168:
156:
137:
122:
113:
89:arginine finger
65:
23:
22:
15:
12:
11:
5:
1060:
1058:
1050:
1049:
1044:
1034:
1033:
1027:
1026:
1024:
1023:
1017:
1015:
1011:
1010:
1007:
1006:
1003:
1002:
1000:
999:
994:
989:
983:
980:
979:
977:
976:
975:
974:
969:
964:
956:
955:
954:
949:
944:
936:
935:
934:
929:
921:
920:
919:
914:
909:
900:
898:
890:
889:
887:
886:
881:
876:
871:
865:
863:
852:
844:
843:
841:
840:
835:
830:
824:
818:
812:
811:
808:
807:
805:
804:
803:
802:
797:
792:
787:
782:
777:
772:
767:
762:
757:
752:
747:
742:
737:
732:
727:
722:
717:
712:
707:
695:
693:
692:Heterotrimeric
689:
688:
686:
685:
684:
683:
678:
668:
667:
666:
661:
651:
650:
649:
644:
633:
631:
624:
618:
617:
612:
610:
609:
602:
595:
587:
581:
580:
568:
567:External links
565:
562:
561:
548:
534:
521:
508:
499:
486:
469:
436:Mol. Microbiol
426:
385:
367:
354:
341:
323:
310:
297:
281:
267:
246:
245:
243:
240:
188:
185:
167:
164:
155:
154:Heterotrimeric
152:
136:
133:
129:protein domain
121:
118:
112:
109:
96:energy barrier
64:
61:
24:
14:
13:
10:
9:
6:
4:
3:
2:
1059:
1048:
1045:
1043:
1040:
1039:
1037:
1022:
1019:
1018:
1016:
1012:
998:
995:
993:
990:
988:
985:
984:
981:
973:
970:
968:
965:
963:
960:
959:
957:
953:
950:
948:
945:
943:
940:
939:
937:
933:
930:
928:
925:
924:
922:
918:
915:
913:
910:
908:
905:
904:
902:
901:
899:
896:
891:
885:
882:
880:
877:
875:
872:
870:
867:
866:
864:
861:
856:
853:
850:
845:
839:
836:
834:
831:
829:
826:
825:
822:
819:
817:
813:
801:
798:
796:
793:
791:
788:
786:
783:
781:
778:
776:
773:
771:
768:
766:
763:
761:
758:
756:
753:
751:
748:
746:
743:
741:
738:
736:
733:
731:
728:
726:
723:
721:
718:
716:
713:
711:
708:
706:
703:
702:
700:
697:
696:
694:
690:
682:
679:
677:
674:
673:
672:
669:
665:
662:
660:
657:
656:
655:
652:
648:
645:
643:
640:
639:
638:
635:
634:
632:
628:
625:
623:
619:
615:
608:
603:
601:
596:
594:
589:
588:
585:
578:
574:
571:
570:
566:
558:
552:
549:
545:
538:
535:
531:
525:
522:
518:
512:
509:
503:
500:
496:
490:
487:
483:
476:
474:
470:
465:
461:
457:
453:
449:
445:
442:(4): 657–67.
441:
437:
430:
427:
422:
418:
413:
408:
405:(9): 6720–6.
404:
400:
399:J. Biol. Chem
396:
389:
386:
382:
376:
374:
372:
368:
364:
358:
355:
351:
345:
342:
338:
332:
330:
328:
324:
320:
314:
311:
307:
301:
298:
294:
288:
286:
282:
270:
264:
260:
259:
251:
248:
241:
234:
230:
222:
218:
215:
205:
201:
198:
194:
186:
184:
182:
176:
172:
165:
163:
161:
153:
151:
149:
144:
142:
134:
132:
130:
126:
119:
117:
110:
104:
100:
97:
94:
90:
80:
76:
72:
70:
62:
60:
58:
53:
49:
45:
41:
37:
33:
29:
19:
621:
556:
551:
543:
537:
529:
524:
516:
511:
502:
494:
489:
481:
439:
435:
429:
402:
398:
388:
380:
362:
357:
349:
344:
337:Biochemistry
336:
318:
313:
305:
300:
292:
272:. Retrieved
257:
250:
227:
210:
190:
180:
177:
173:
169:
157:
145:
138:
123:
114:
85:
73:
66:
35:
31:
27:
26:
274:15 December
160:RGS protein
48:RGS protein
1036:Categories
242:References
166:Regulation
40:G proteins
630:Monomeric
135:Monomeric
63:Mechanism
1047:Proteins
838:Ras-GRF1
637:Chimerin
495:Oncogene
421:11092890
162:family.
958:DOCK-D
938:DOCK-C
923:DOCK-B
903:DOCK-A
464:8187706
456:2191183
350:Science
237:tumors.
195:. The
997:IQSEC2
972:Dock11
967:Dock10
849:RhoGEF
654:RasGAP
579:(MeSH)
557:Nature
462:
454:
419:
265:
44:GTPase
1014:Other
962:Dock9
952:Dock8
947:Dock7
942:Dock6
932:Dock4
927:Dock3
917:Dock5
912:Dock2
907:DOCK1
828:EIF2B
800:RGS21
795:RGS20
790:RGS19
785:RGS18
780:RGS17
775:RGS16
770:RGS14
765:RGS13
760:RGS12
755:RGS11
750:RGS10
664:IQGAP
460:S2CID
306:Blood
992:SIL1
987:ALS2
895:DOCK
884:FGD4
879:FGD3
874:FGD2
869:FGD1
745:RGS9
740:RGS8
735:RGS7
730:RGS6
725:RGS5
720:RGS4
715:RGS3
710:RGS2
705:RGS1
681:TSC2
676:TSC1
647:CHN2
642:CHN1
452:PMID
417:PMID
276:2010
263:ISBN
125:EIF5
36:GAPs
860:FGD
659:NF1
444:doi
407:doi
403:276
181:off
148:Ran
141:Ras
30:or
1038::
701::
472:^
458:.
450:.
438:.
415:.
401:.
397:.
370:^
326:^
284:^
606:e
599:t
592:v
466:.
446::
440:4
423:.
409::
278:.
34:(
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.